Our planet or our patients-is the sky the limit for inhaler choice?

Lancet Respir Med. 2019 Jan;7(1):11-13. doi: 10.1016/S2213-2600(18)30497-1. Epub 2018 Dec 12.

Authors

Omar S Usmani¹, Jane Scullion², Duncan Keeley³

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK. Electronic address: [email protected].
² University Hospitals of Leicester NHS Trust, Leicester, UK.
³ Thame, UK.

PMID: 30553845
DOI: 10.1016/S2213-2600(18)30497-1

No abstract available

MeSH terms

Asthma / drug therapy
Climate Change*
Health Policy / legislation & jurisprudence
Humans
Hydrocarbons, Fluorinated / adverse effects
Nebulizers and Vaporizers*
United Kingdom

Substances

Hydrocarbons, Fluorinated
apaflurane